NCT04536428

Brief Summary

We are going to conduct a comparative study to analyze the clinical effectiveness and user convenience of EZ clips that have been used in upper gastrointestinal ulcer bleeding and newly developed clip (ClearEndoclip, FineMedix, Taegu) in Korea. 1\) Research hypothesis and purpose

  • This study was designed to prove the hypothesis that the hemostatic effect of newly developed endoscopic clip (ClearEndoclip, FineMedix, Taegu, Korea) is not inferior to that of EZ clip (Olympus, Tokyo, Japan) in the treatment of hemostasis for patients who visited the upper gastrointestinal ulcer bleeding.
  • This study was designed as a multi-center (9 institutions), open-labelled, randomized comparative clinical trial (1:1 ratio).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
176

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2020

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 6, 2020

Completed
18 days until next milestone

Study Start

First participant enrolled

August 24, 2020

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 2, 2020

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2021

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
Last Updated

September 2, 2020

Status Verified

August 1, 2020

Enrollment Period

11 months

First QC Date

August 6, 2020

Last Update Submit

August 31, 2020

Conditions

Keywords

peptic ulcerhemorrhagestomachduodenum

Outcome Measures

Primary Outcomes (1)

  • Rebleeding rate after endoscopic hemostasis

    The rate of rebleeding at the site of bleeding within 7 days after the first endoscopic hemostasis, which should be identified endoscopically.

    upto 7 days

Secondary Outcomes (2)

  • Satisfaction scores of the operator and the assistant

    during endoscopic procedure

  • Failure rate of clip installation

    during endoscopic procedure

Study Arms (2)

ClearEndoclip

EXPERIMENTAL

This arm is a group in whom ClearEndoclip would be used for the treatment of bleeding.

Device: Endoscopic hemostasis with clip

EZ clip

ACTIVE COMPARATOR

This arm is a group in whom EZ clip would be used for the treatment of bleeding.

Device: Endoscopic hemostasis with clip

Interventions

This intervention is performed as the following orders. * The tip of endoscope is accessed to a bleeding site. * The accurate visualization of bleeding site is done. * A sheath of delivery system of clip is inserted through a working channel of endoscope. * The end of clip is opened in front of the bleeding site. If needed, clip could be rotated to adjust to a bleeding target. * The both ends of clip are placed on both sides of a bleeding site. * If bleeding is still continued, additional placements of clip are tried until bleeding stops.

ClearEndoclipEZ clip

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men and women aged 20 to 80
  • The patients who came to the emergency room due to upper gastrointestinal bleeding with as follows: peptic ulcer with acute bleeding or protruding vascular exposure (Forrest class Ia-IIa), anastomotic vascular ulcer bleeding, bleeding from endoscopic submucosal dissection or endoscopic mucosal resection site after 24 hours
  • American Society of Anesthesiologist (ASA) Physical Status 1 - 3
  • Patients with adequate patient compliance and adequate geographical distance for follow-up. character

You may not qualify if:

  • Patients with gastrointestinal bleeding who are not recommended to clip Bleeding from a malignant tumor Hemorrhagic gastritis Angiodysplasia variceal bleeding
  • Bleeding during endoscopic submucosal dissection or endoscopic mucosal resection
  • Patients with insufficient clinical information
  • Pregnant or lactating patients
  • Patients or guardians who have not obtained informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sun Gyo Lim

Suwon, Gyeonggi-do, 16499, South Korea

Location

MeSH Terms

Conditions

Peptic Ulcer HemorrhagePeptic UlcerHemorrhage

Interventions

Hemostasis, EndoscopicSurgical Instruments

Condition Hierarchy (Ancestors)

Gastrointestinal HemorrhageGastrointestinal DiseasesDigestive System DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsDuodenal DiseasesIntestinal DiseasesStomach Diseases

Intervention Hierarchy (Ancestors)

Hemostatic TechniquesTherapeuticsSurgical EquipmentEquipment and Supplies

Study Officials

  • Sun Gyo Lim

    Department of Gastroenterology, Ajou University School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

August 6, 2020

First Posted

September 2, 2020

Study Start

August 24, 2020

Primary Completion

July 31, 2021

Study Completion

December 1, 2021

Last Updated

September 2, 2020

Record last verified: 2020-08

Locations